CITIUS ONCOLOGY, INC. (CTOR)
Pharmaceutical Preparations
Latest Price
$0.92
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.37
P/B Ratio
2.45
Institutional Ownership
13.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 8.71M | $5.0M | 8.23% | -483.3K | 2026-06-30 |
| BANK OF AMERICA CORP /DE/ | 3.84M | $2.0M | 3.63% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 546.3K | -- | 0.52% | +11.5K | 2026-06-30 |
| UBS Group AG | 334.6K | -- | 0.32% | +297.8K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 245.4K | -- | 0.23% | -19.3K | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 121.9K | -- | 0.12% | -- | 2026-06-30 |
| IFP Advisors, Inc | 107.4K | -- | 0.10% | +85.2K | 2026-06-30 |
| CITADEL ADVISORS LLC | 90.6K | -- | 0.09% | +72.9K | 2026-06-30 |
| NORTHERN TRUST CORP | 45.7K | -- | 0.04% | -- | 2026-06-30 |
| STATE STREET CORP | 42.9K | -- | 0.04% | -- | 2026-06-30 |